发明名称 | Nanoceria for the treatment of oxidative stress | ||
摘要 | A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury. | ||
申请公布号 | US9533007(B2) | 申请公布日期 | 2017.01.03 |
申请号 | US201514690781 | 申请日期 | 2015.04.20 |
申请人 | CERION, LLC | 发明人 | Reed Kenneth Joseph;Costanzo Wendi Ann;Erlichman Joseph Samuel;Bell Eric Leslie |
分类号 | A61K9/16;A61K33/24;A61K9/10;B82Y5/00;B01J13/02 | 主分类号 | A61K9/16 |
代理机构 | RatnerPrestia | 代理人 | RatnerPrestia |
主权项 | 1. A pharmaceutical composition for the treatment of a patient suffering from a disease associated with oxidative stress comprising a therapeutically effective amount of a dispersion of cerium-containing nanoparticles and optionally a pharmaceutically acceptable excipient, wherein the cerium-containing nanoparticles are stabilized by citric acid and ethylenediaminetetraacetic acid. | ||
地址 | Rochester NY US |